融眾金融(03963.HK)6,000元售宏田創投股份49%股權
融眾金融(03963.HK)公布,與(木通)熥訂立買賣協議及股東協議,以開展與(木通)熥的建議合作。據此,公司將以6,000元出售購49股宏田創投股份予(木通)熥,佔宏田創投已發行股本總額的49%。
宏田創投為一間投資控股公司並為集團之直接全資附屬公司。目前宏田創投尚未開展任何業務,且除100美元的名義股本外,並無擁有任何資產。於出售事項完成後,宏田創投將由集團及(木通)熥分別擁有51%及49%,並將為集團之非全資附屬公司。宏田創投將成為於香港提供信貸管理服務的服務供應商。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.